103 related articles for article (PubMed ID: 27834032)
21. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
[TBL] [Abstract][Full Text] [Related]
22. Effects of 5-FU and anti-EGFR antibody in combination with ASA on the spherical culture system of HCT116 and HT29 colorectal cancer cell lines.
Olejniczak-Kęder A; Szaryńska M; Wrońska A; Siedlecka-Kroplewska K; Kmieć Z
Int J Oncol; 2019 Jul; 55(1):223-242. PubMed ID: 31180528
[TBL] [Abstract][Full Text] [Related]
23. In vitro chemosensitivity based on depth of invasion in advanced colorectal cancer using ATP-based chemotherapy response assay (ATP-CRA).
Cho YB; Lee WY; Song SY; Choi SH; Shin HJ; Ahn KD; Lee JM; Kim HC; Yun SH; Chun HK
Eur J Surg Oncol; 2009 Sep; 35(9):951-6. PubMed ID: 19181477
[TBL] [Abstract][Full Text] [Related]
24. Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.
Usui T; Sakurai M; Umata K; Elbadawy M; Ohama T; Yamawaki H; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Sato K; Kaneda M; Sasaki K
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642386
[TBL] [Abstract][Full Text] [Related]
25. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
26. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
27. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
28. SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance.
Munakata K; Uemura M; Takemasa I; Ozaki M; Konno M; Nishimura J; Hata T; Mizushima T; Haraguchi N; Noura S; Ikenaga M; Okamura S; Fukunaga M; Murata K; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2014 May; 44(5):1521-8. PubMed ID: 24585249
[TBL] [Abstract][Full Text] [Related]
29. Identification of Sestrin3 Involved in the In vitro Resistance of Colorectal Cancer Cells to Irinotecan.
Choi SH; Hong HK; Cho YB; Lee WY; Yoo HY
PLoS One; 2015; 10(5):e0126830. PubMed ID: 25973791
[TBL] [Abstract][Full Text] [Related]
30. Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissues.
Tong M; Zheng W; Lu X; Ao L; Li X; Guan Q; Cai H; Li M; Yan H; Guo Y; Chi P; Guo Z
Oncotarget; 2015 Dec; 6(38):41216-27. PubMed ID: 26515599
[TBL] [Abstract][Full Text] [Related]
31. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38.
Zhou Y; Bollu LR; Tozzi F; Ye X; Bhattacharya R; Gao G; Dupre E; Xia L; Lu J; Fan F; Bellister S; Ellis LM; Weihua Z
Mol Cancer Ther; 2013 Dec; 12(12):2782-91. PubMed ID: 24132143
[TBL] [Abstract][Full Text] [Related]
32. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
[TBL] [Abstract][Full Text] [Related]
33. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Li T; Gao F; Zhang XP
Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
[TBL] [Abstract][Full Text] [Related]
34. Cell-surface markers for colon adenoma and adenocarcinoma.
Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
[TBL] [Abstract][Full Text] [Related]
35. Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance.
Zhang Y; Huang L; Shi H; Chen H; Tao J; Shen R; Wang T
Cancer Sci; 2018 Jan; 109(1):94-102. PubMed ID: 29034540
[TBL] [Abstract][Full Text] [Related]
36. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic"
Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T
Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines.
Zhao R; Quaroni L; Casson AG
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1192-9. PubMed ID: 22980068
[TBL] [Abstract][Full Text] [Related]
38. Effect of mTHPC-mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells.
Kukcinaviciute E; Sasnauskiene A; Dabkeviciene D; Kirveliene V; Jonusiene V
Photochem Photobiol Sci; 2017 Jul; 16(7):1063-1070. PubMed ID: 28509917
[TBL] [Abstract][Full Text] [Related]
39. Novel activity of acriflavine against colorectal cancer tumor cells.
Hassan S; Laryea D; Mahteme H; Felth J; Fryknäs M; Fayad W; Linder S; Rickardson L; Gullbo J; Graf W; Påhlman L; Glimelius B; Larsson R; Nygren P
Cancer Sci; 2011 Dec; 102(12):2206-13. PubMed ID: 21910782
[TBL] [Abstract][Full Text] [Related]
40. Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.
Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
Drug Resist Updat; 2011 Dec; 14(6):280-96. PubMed ID: 21955833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]